1. Home
  2. PKE vs NKTR Comparison

PKE vs NKTR Comparison

Compare PKE & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKE
  • NKTR
  • Stock Information
  • Founded
  • PKE 1954
  • NKTR 1990
  • Country
  • PKE United States
  • NKTR United States
  • Employees
  • PKE N/A
  • NKTR N/A
  • Industry
  • PKE Military/Government/Technical
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PKE Industrials
  • NKTR Health Care
  • Exchange
  • PKE Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • PKE 285.7M
  • NKTR 247.9M
  • IPO Year
  • PKE N/A
  • NKTR 1994
  • Fundamental
  • Price
  • PKE $13.77
  • NKTR $0.93
  • Analyst Decision
  • PKE
  • NKTR Strong Buy
  • Analyst Count
  • PKE 0
  • NKTR 5
  • Target Price
  • PKE N/A
  • NKTR $4.50
  • AVG Volume (30 Days)
  • PKE 51.3K
  • NKTR 3.0M
  • Earning Date
  • PKE 01-14-2025
  • NKTR 03-07-2025
  • Dividend Yield
  • PKE 3.63%
  • NKTR N/A
  • EPS Growth
  • PKE N/A
  • NKTR N/A
  • EPS
  • PKE 0.36
  • NKTR N/A
  • Revenue
  • PKE $61,420,000.00
  • NKTR $93,137,000.00
  • Revenue This Year
  • PKE N/A
  • NKTR $12.15
  • Revenue Next Year
  • PKE N/A
  • NKTR N/A
  • P/E Ratio
  • PKE $38.22
  • NKTR N/A
  • Revenue Growth
  • PKE 15.45
  • NKTR 5.53
  • 52 Week Low
  • PKE $11.96
  • NKTR $0.63
  • 52 Week High
  • PKE $16.96
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • PKE 36.08
  • NKTR 53.83
  • Support Level
  • PKE $13.95
  • NKTR $0.92
  • Resistance Level
  • PKE $14.30
  • NKTR $1.08
  • Average True Range (ATR)
  • PKE 0.34
  • NKTR 0.09
  • MACD
  • PKE -0.07
  • NKTR 0.03
  • Stochastic Oscillator
  • PKE 0.00
  • NKTR 65.63

About PKE Park Aerospace Corp.

Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: